Opposite effects of SDF-1 on human immunodeficiency virus type 1 replication.
about
Interleukin-8 stimulates human immunodeficiency virus type 1 replication and is a potential new target for antiretroviral therapyCD8(+)-Cell antiviral factor activity is not restricted to human immunodeficiency virus (HIV)-specific T cells and can block HIV replication after initiation of reverse transcription.CD40-Mediated induction of CD4 and CXCR4 on B lymphocytes correlates with restricted susceptibility to human immunodeficiency virus type 1 infection: potential role of B lymphocytes as a viral reservoir.Human immunodeficiency virus type 1 (HIV-1)-induced GRO-alpha production stimulates HIV-1 replication in macrophages and T lymphocytesImpact of the placental cytokine-chemokine balance on regulation of cell-cell contact-induced human immunodeficiency virus type 1 translocation across a trophoblastic barrier in vitro.Preferential vulnerability of astroglia and glial precursors to combined opioid and HIV-1 Tat exposure in vitro.Innate immunity in the vagina (Part II): Anti-HIV activity and antiviral content of human vaginal secretionsB cells of HIV-1-infected patients bind virions through CD21-complement interactions and transmit infectious virus to activated T cells.Human uterine natural killer cells but not blood natural killer cells inhibit human immunodeficiency virus type 1 infection by secretion of CXCL12.Inhibition of human immunodeficiency virus replication by a dual CCR5/CXCR4 antagonist.Mechanisms involved in stimulation of human immunodeficiency virus type 1 replication by aminooxypentane RANTES.Combination of CCR5 and CXCR4 inhibitors in therapy of human immunodeficiency virus type 1 infection: in vitro studies of mixed virus infections.G protein-dependent CCR5 signaling is not required for efficient infection of primary T lymphocytes and macrophages by R5 human immunodeficiency virus type 1 isolatesPoly (I:C) and LPS induce distinct immune responses by ovarian stromal fibroblasts.
P2860
Q24291516-21751569-F660-461A-AAE8-5FF7D4BF6C75Q33804193-DC9FCB00-4162-4237-AA41-368167FE93A6Q33818747-D460F92D-5FF2-4766-8A18-8DFF1CDBA5CFQ33842216-E430ECD4-9CF6-4AF2-8EA5-114E62BAE480Q33984163-DFCBEE0B-D062-4501-B592-C2A471B4CA53Q35009483-765F6189-7EB6-4546-AF01-40AFA0C8E768Q35078336-427230DC-FC03-4AFC-8FDC-8B687F9FDF0BQ36368837-B0E9028B-6D0D-4B2D-B59B-0A0203C8B71CQ37410808-726008BB-ADF6-431A-8489-DDDB23CE4ECCQ37596456-15E8F72A-55B5-48B1-BE3E-95C30DB209E1Q39216644-899F2017-F6A6-44B6-A101-A4F0AF4AA8AAQ39539977-C0AC6B29-0D53-4437-9823-22F0BA31036EQ39700255-FB470E35-B959-4F66-AC44-9BD4F93F5C83Q54212481-8C3FA87A-C77E-4379-87AA-399F5AE9D101
P2860
Opposite effects of SDF-1 on human immunodeficiency virus type 1 replication.
description
1999 nî lūn-bûn
@nan
1999 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
1999 թվականի մայիսին հրատարակված գիտական հոդված
@hy
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
name
Opposite effects of SDF-1 on human immunodeficiency virus type 1 replication.
@ast
Opposite effects of SDF-1 on human immunodeficiency virus type 1 replication.
@en
type
label
Opposite effects of SDF-1 on human immunodeficiency virus type 1 replication.
@ast
Opposite effects of SDF-1 on human immunodeficiency virus type 1 replication.
@en
prefLabel
Opposite effects of SDF-1 on human immunodeficiency virus type 1 replication.
@ast
Opposite effects of SDF-1 on human immunodeficiency virus type 1 replication.
@en
P2093
P2860
P1433
P1476
Opposite effects of SDF-1 on human immunodeficiency virus type 1 replication.
@en
P2093
F Arenzana-Seisdedos
O Schwartz
V Maréchal
P2860
P304
P577
1999-05-01T00:00:00Z